These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26384282)

  • 1. Myeloma escape from immunity: an "inside" job.
    Rapoport AP
    Blood; 2015 Sep; 126(12):1401-3. PubMed ID: 26384282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing.
    Leone P; Berardi S; Frassanito MA; Ria R; De Re V; Cicco S; Battaglia S; Ditonno P; Dammacco F; Vacca A; Racanelli V
    Blood; 2015 Sep; 126(12):1443-51. PubMed ID: 26185130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
    Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
    Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
    Marchica V; Accardi F; Storti P; Mancini C; Martella E; Dalla Palma B; Bolzoni M; Todoerti K; Marcatti M; Schifano C; Bonomini S; Sammarelli G; Neri A; Ponzoni M; Aversa F; Giuliani N
    Int J Hematol; 2017 Jan; 105(1):104-108. PubMed ID: 27699576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human long-term bone marrow cultures (HLTBMCs) in myelomatous disorders.
    Berneman ZN; Chen ZZ; Ramael M; Van Hoof V; Peetermans ME
    Leukemia; 1989 Feb; 3(2):151-4. PubMed ID: 2911207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
    Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
    Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
    Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
    Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bone marrow sections, smears and immunohistological staining for immunoglobulin light chains in the diagnosis of benign and malignant plasma cell proliferations.
    Thiry A; Delvenne P; Fontaine MA; Boniver J
    Histopathology; 1993 May; 22(5):423-8. PubMed ID: 7688339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-marrow plasmocytosis--an immunohistological study.
    Eckert F; Schmid L; Kradolfer D; Schmid U
    Blut; 1986 Jul; 53(1):11-9. PubMed ID: 3719110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma.
    Singhal S; Mehta J
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1322-30. PubMed ID: 17699365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary cutaneous plasmacytoma revealing multiple myeloma: about a case].
    Ngolet LO; N'soundhat NL; Ndounga E; Kocko I; Kidédé DC; Ntsiba H
    Pan Afr Med J; 2016; 24():44. PubMed ID: 27642385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological grading and clinical staging of plasmacytoma.
    Hokamp HG; Grundmann E
    J Cancer Res Clin Oncol; 1983; 105(2):197-8. PubMed ID: 6826641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 14. Levels of CD8+ tumor infiltrating lymphocytes correlate with disease burden in bone marrow of therapy Naïve multiple myeloma patients.
    Hidalgo-Lopez JE; Higa MG; Ferrian S; Lin P; Blando J; Medeiros LJ; Bueso-Ramos CE
    Ann Diagn Pathol; 2019 Jun; 40():174-175. PubMed ID: 30509755
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow microenvironmental CD4 + and CD8 + lymphocyte infiltration patterns define overall- and progression free survival in standard risk multiple myeloma--an analysis from the Austrian Myeloma Registry.
    Willenbacher W; Willenbacher E; Zelle-Rieser C; Biedermann R; Weger R; Jöhrer K; Brunner A
    Leuk Lymphoma; 2016; 57(6):1478-81. PubMed ID: 26413883
    [No Abstract]   [Full Text] [Related]  

  • 16. Catheter insertion site plasmacytoma.
    Arango M; Echeverri C
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):34-5. PubMed ID: 26276079
    [No Abstract]   [Full Text] [Related]  

  • 17. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
    Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
    Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maxillary plasmacytoma/plasma cell myeloma.
    Glover GR; Nesbitt JA; North AF
    Oral Surg Oral Med Oral Pathol; 1987 Dec; 64(6):680-6. PubMed ID: 3480484
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma cell dyscrasias.
    Buss DH; Prichard RW; Cooper MR
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):603-15. PubMed ID: 3065321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmablastic multiple myeloma with Dutcher bodies.
    Jain D; Singh T
    Indian J Pathol Microbiol; 2008; 51(3):442-3. PubMed ID: 18723987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.